LifeMD Non Current Assets Total from 2010 to 2025
| LFMD Stock | USD 5.45 0.15 2.68% |
Non Current Assets Total | First Reported 2012-09-30 | Previous Quarter 23.9 M | Current Value 23.7 M | Quarterly Volatility 8.5 M |
Check LifeMD financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LifeMD's main balance sheet or income statement drivers, such as Depreciation And Amortization of 10 M, Interest Expense of 2.3 M or Selling General Administrative of 76.3 M, as well as many indicators such as Price To Sales Ratio of 0.91, Dividend Yield of 0.0138 or Days Sales Outstanding of 14.8 M. LifeMD financial statements analysis is a perfect complement when working with LifeMD Valuation or Volatility modules.
LifeMD | Non Current Assets Total |
Latest LifeMD's Non Current Assets Total Growth Pattern
Below is the plot of the Non Current Assets Total of LifeMD Inc over the last few years. It is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. LifeMD's Non Current Assets Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in LifeMD's overall financial position and show how it may be relating to other accounts over time.
| Non Current Assets Total | 10 Years Trend |
|
Non Current Assets Total |
| Timeline |
LifeMD Non Current Assets Total Regression Statistics
| Arithmetic Mean | 3,040,016,219,666 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 273.34 | |
| Mean Deviation | 5,320,023,551,334 | |
| Median | 699,077 | |
| Standard Deviation | 8,309,721,510,535 | |
| Sample Variance | 69051471582655.1T | |
| Range | 24.9T | |
| R-Value | 0.57 | |
| Mean Square Error | 49544207060958.8T | |
| R-Squared | 0.33 | |
| Significance | 0.02 | |
| Slope | 1,003,161,436,317 | |
| Total Sum of Squares | 1035772073739826.2T |
LifeMD Non Current Assets Total History
About LifeMD Financial Statements
LifeMD stakeholders use historical fundamental indicators, such as LifeMD's Non Current Assets Total, to determine how well the company is positioned to perform in the future. Although LifeMD investors may analyze each financial statement separately, they are all interrelated. For example, changes in LifeMD's assets and liabilities are reflected in the revenues and expenses on LifeMD's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in LifeMD Inc. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Non Current Assets Total | 23.7 T | 24.9 T |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out the analysis of LifeMD Correlation against competitors. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LifeMD. If investors know LifeMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LifeMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.50) | Revenue Per Share | Quarterly Revenue Growth 0.432 | Return On Assets | Return On Equity |
The market value of LifeMD Inc is measured differently than its book value, which is the value of LifeMD that is recorded on the company's balance sheet. Investors also form their own opinion of LifeMD's value that differs from its market value or its book value, called intrinsic value, which is LifeMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LifeMD's market value can be influenced by many factors that don't directly affect LifeMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LifeMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if LifeMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LifeMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.